Bibliographic citations
Chavez, E., Serna, N. (2024). Conocimientos, actitudes, prácticas y barreras sobre la vacuna contra la influenza entre adultos en un establecimiento de atención primaria de salud del sector público, en un distrito de Lima, enero 2024 [Universidad María Auxiliadora]. https://hdl.handle.net/20.500.12970/2356
Chavez, E., Serna, N. Conocimientos, actitudes, prácticas y barreras sobre la vacuna contra la influenza entre adultos en un establecimiento de atención primaria de salud del sector público, en un distrito de Lima, enero 2024 []. PE: Universidad María Auxiliadora; 2024. https://hdl.handle.net/20.500.12970/2356
@misc{renati/1031681,
title = "Conocimientos, actitudes, prácticas y barreras sobre la vacuna contra la influenza entre adultos en un establecimiento de atención primaria de salud del sector público, en un distrito de Lima, enero 2024",
author = "Serna Saavedra, Nedabia",
publisher = "Universidad María Auxiliadora",
year = "2024"
}
Objective: to determine the knowledge, attitudes, practices, and barriers regarding the influenza vaccine among adults in a primary healthcare facility in the public sector. Materials and Methods: a quantitative, basic, cross-sectional study was conducted. Data were collected using a structured questionnaire. Participants were selected through voluntary sampling. Data were analyzed using SPSS version 25, with p-values < 0.05 considered statistically significant. Results: of 200 participants, 53% had a high level of knowledge, and 93.5% had a favorable attitude toward influenza vaccination. Approximately 72.5% of respondents adopted acceptable practices leading to vaccination. The main barriers to influenza vaccination included concerns about adverse effects (61%) and lack of information about the influenza vaccine (55.5%). Conclusions: despite a high level of knowledge about the influenza vaccine, its uptake remains limited. The paradigm shift should focus not only on vaccine knowledge and immunization but also on attitudes and practices that eliminate barriers to vaccine access.
This item is licensed under a Creative Commons License